Cell BiologyEMBO Molecular MedicinePeer-reviewed
A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma.
Hanhee Jo, Sarah Munoz, Aneesh Dalvi…·Stacey M. Glasgow
This study identifies NUAK2 as a fetal oncogene in glioblastoma, showing its role in promoting cell proliferation and migration, and demonstrates that its inhibition can suppress tumor growth.